 |
Vascular Access Changing Scenario and Challenges in India
Vasanth Kumar Reddy, MD |
|
Anatomic and physiologic basis for Vascular access planning
Surendra Shenoy MD |
|
Patient Evaluation Prior to Access Placement
Gerald Beathard, MD |
|
Panel Discussion
Drs. Reddy, Shenoy, and Beathard |
|
The role of Long acting ESA – Darbepoietin in the current management of Anaemia
L H Surathkal, MD |
|
Round table discussion on Darbepoietin
Drs. Misra, Surathkal, Beathard, Chan, Canaud, Davenport, Daugirdas, Nayak, Ahmad, Shenoy, Gura, and Marshall |
Vasanth Kumar Reddy, MD
Consultant Vascular & Transplant Surgeon
Hyderabad, India
Surendra Shenoy, MD
Washington University School of medicine
St. Louis, Missouri
Gerald A. Beathard, MD
Clinical Professor
University of Texas Medical Branch
LH Suratkal, MD
Nephrologist
Lilavathi Hospital
Mumbai, India |
|
 |
This educational activity is an audio recording with accompanying slides of a live presentation
held on March 1st and 2nd, 2014, in Hyderabad, India. Continuing medical education credit is not available for this on-line archive.
The Web archiving and presentation of this symposium was made possible by an unrestricted educational grant from Baxter Healthcare to the International Society for Hemodialysis.
To view this educational activity, the user will need Windows (XP or higher) or
Macintosh (version 9.0 or higher) operating software, a connection to the internet with a
28.8 kbps MODEM or better. The computer should have an audio card with speakers.
An audio player is required and either can be downloaded for free per instructions on the individual lecture pages.
Flash 8.0 (from www.adobe.com) is useful but not necessary to see the full-screen slide/audio presentations and the video presentations.
Acrobat Reader is required to print the slide handouts.
Program Overview:
Target Audience:
This program is intended for practicing
Nephrologists, nephrology fellows, dialysis
technologists, interventional nephrologists,
vascular access surgeons, and health professionals
involved in dialysis programs.
| SPEAKER DISCLOSURE STATEMENT and OFF-LABEL USE: |
Disclosure Policy:
It is the policy of the ISHD and HDCN that speakers with potential conflicts of interest disclose these at the time of presentation.
Off-label/lnvestigational Use:
Because this course is meant to educate physicians with what is currently in use and what may be
available in the future, there may be "off-label" use discussed in the presentations. Speakers have
been requested to inform the audience when off-label use is being discussed.
The policy statements of HDCN are listed on this page.
|
|
